Global Cancer Biopharmaceuticals Market Size, Status and Forecast 2019-2025

SKU ID : QYR- 13468086

Publishing Date : 16-May-2019

No. of pages : 109

PRICE
3900
7800


  • Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Cancer is a complex invasive genetic disease that causes significant mortality rate worldwide. Cancer drugs are the primary concern in terms of drug development trends.
    In 2018, the global Cancer Biopharmaceuticals market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

    This report focuses on the global Cancer Biopharmaceuticals status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Biopharmaceuticals development in United States, Europe and China.

    The key players covered in this study
    Sanofi
    Johnson & Johnson
    Pfizer
    Novartis
    Merck
    GlaxoSmithKline
    Eli Lilly
    Agios Pharmaceuticals
    Bristol-Myers Squibb
    AstraZeneca
    Mylan
    LEO Pharma
    Boehringer Ingelheim
    Alexion Pharmaceuticals
    Elusys Therapeutics

    Market segment by Type, the product can be split into
    Biologics
    Biosimilars

    Market segment by Application, split into
    Liquid Cancers
    Solid Cancers

    Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Cancer Biopharmaceuticals status, future forecast, growth opportunity, key market and key players.
    To present the Cancer Biopharmaceuticals development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

    In this study, the years considered to estimate the market size of Cancer Biopharmaceuticals are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.